The non-alcoholic steatohepatitis biomarkers market is experiencing an unprecedented growth trajectory, fueled by the increasing prevalence of liver diseases, rising demand for non-invasive diagnostic solutions, and continuous advancements in biomarker discovery. According to recent industry analysis, the global NASH biomarkers market size was valued at USD 1.14 billion in 2023 and is...